96 related articles for article (PubMed ID: 23273510)
1. Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.
Ogilvie GS; Cook DA; Taylor DL; Rank C; Kan L; Yu A; Mei W; van Niekerk DJ; Coldman AJ; Krajden M
Vaccine; 2013 Feb; 31(7):1129-33. PubMed ID: 23273510
[TBL] [Abstract][Full Text] [Related]
2. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
3. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
[TBL] [Abstract][Full Text] [Related]
4. Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.
Lindemann ML; Dominguez MJ; de Antonio JC; Sandri MT; Tricca A; Sideri M; Khiri H; Ravet S; Boyle S; Aldrich C; Halfon P
J Mol Diagn; 2012 Jan; 14(1):65-70. PubMed ID: 22079749
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
6. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
7. Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland.
Dobec M; Bannwart F; Kaeppeli F; Cassinotti P
J Clin Virol; 2009 May; 45(1):23-7. PubMed ID: 19375383
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the compatibility of the Digene media when performing the Roche linear array human papillomavirus genotyping test.
Hong JH; Lee JK; Song ES; Lee JM; Kim MK
Arch Gynecol Obstet; 2009 Oct; 280(4):613-8. PubMed ID: 19229548
[TBL] [Abstract][Full Text] [Related]
9. High-risk HPV prevalence among women undergoing cervical cancer screening: Findings a decade after HPV vaccine implementation in British Columbia, Canada.
Litwin C; Smith L; Donken R; Krajden M; van Niekerk D; Naus M; Cook D; Albert A; Ogilvie G
Vaccine; 2021 Aug; 39(36):5198-5204. PubMed ID: 34344555
[TBL] [Abstract][Full Text] [Related]
10. HPV Direct Flow CHIP: a new human papillomavirus genotyping method based on direct PCR from crude-cell extracts.
Herraez-Hernandez E; Alvarez-Perez M; Navarro-Bustos G; Esquivias J; Alonso S; Aneiros-Fernandez J; Lacruz-Pelea C; Sanchez-Aguera M; Santamaria JS; de Antonio JC; Rodriguez-Peralto JL
J Virol Methods; 2013 Oct; 193(1):9-17. PubMed ID: 23680093
[TBL] [Abstract][Full Text] [Related]
11. Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study.
Učakar V; Poljak M; Klavs I
Vaccine; 2012 Jan; 30(2):116-20. PubMed ID: 22080175
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.
Castellsagué X; Iftner T; Roura E; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; San Martin Rodriguez M; Serradell L; Torcel-Pagnon L; Cortes J;
J Med Virol; 2012 Jun; 84(6):947-56. PubMed ID: 22499018
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study.
Iftner T; Eberle S; Iftner A; Holz B; Banik N; Quint W; Straube AN
J Med Virol; 2010 Nov; 82(11):1928-39. PubMed ID: 20872721
[TBL] [Abstract][Full Text] [Related]
14. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities.
Pannier-Stockman C; Segard C; Bennamar S; Gondry J; Boulanger JC; Sevestre H; Castelain S; Duverlie G
J Clin Virol; 2008 Aug; 42(4):353-60. PubMed ID: 18485810
[TBL] [Abstract][Full Text] [Related]
16. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
[TBL] [Abstract][Full Text] [Related]
18. HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia.
Stevens MP; Garland SM; Tan JH; Quinn MA; Petersen RW; Tabrizi SN
J Med Virol; 2009 Jul; 81(7):1283-91. PubMed ID: 19475612
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
[TBL] [Abstract][Full Text] [Related]
20. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
